 | • レポートコード：20QY06-02563 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ナタマイシンのグローバル市場について種類別（ナタマイシン50％、ナタマイシン95％）、用途別（食品産業、医療、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ナタマイシン市場の概要 ・世界の主要地域別ナタマイシン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のナタマイシン市場規模2015-2026：種類別（ナタマイシン50％、ナタマイシン95％） ・世界のナタマイシン市場規模2015-2026：用途別（食品産業、医療、その他） ・ナタマイシンの北米市場規模2015-2020 ・ナタマイシンのヨーロッパ市場規模2015-2020 ・ナタマイシンの中国市場規模2015-2020 ・ナタマイシンの日本市場規模2015-2020 ・ナタマイシンの東南アジア市場規模2015-2020 ・ナタマイシンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Danisco、DSM、VGP、Handary、AMTECH BIOTECH、Silver-Elephant、Lanzhou Weiri、Langfang Meihua、Zhengzhou New Frey、Chihon、Jiaozuo Joincare、Beijing Oriental Rada、Pucheng Lifecome） ・ナタマイシンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ナタマイシンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Natamycin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Natamycin market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Natamycin market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Natamycin industry.
Based on our recent survey, we have several different scenarios about the Natamycin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 163.1 million in 2019. The market size of Natamycin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Natamycin market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Natamycin market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Natamycin market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Natamycin market. The report also includes nautical information, where it shows Natamycin market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Natamycin market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Natamycin market.
Raw Materials are important component, occupying for the most proportion of cost. It’s important and necessary to attach importance to raw materials sourcing.
In general, the raw materials need to outsourcing, and the price, on-time rate and quality are very key indicators, to keep competitive market position, to maximize the profit.
Actually, the price, on-time rate or quality, is just one of key factors to influence on the supply capacity and competitiveness. The lowest total production cost is the total index to maximize the profit.
To a producer, can control the total production cost through worldwide procurement, localization procurement and concentrative purchase, more purchasing focuses on fewer suppliers to large-scale purchase, to large-scale and high efficiency. Now the logistics and information is well-developed, beneficial to worldwide procurement, localization procurement and concentrative purchase. In future, more manufacturers will attach importance to the raw materials purchasing,
Geographical Analysis:
Based on region, the global Natamycin market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Natamycin market are
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
Segment by Type
Natamycin 50%
Natamycin 95%
Segment by Application
Food industry
Medical
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Natamycin market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Natamycin market.
• The market share of the global Natamycin market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Natamycin market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Natamycin market.
1 Natamycin Market Overview
1.1 Natamycin Product Scope
1.2 Natamycin Segment by Type
1.2.1 Global Natamycin Sales by Type (2020-2026)
1.2.2 Natamycin 50%
1.2.3 Natamycin 95%
1.3 Natamycin Segment by Application
1.3.1 Global Natamycin Sales Comparison by Application (2020-2026)
1.3.2 Food industry
1.3.3 Medical
1.3.4 Others
1.4 Natamycin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Natamycin Sales Growth Rate (2015-2026)
1.4.2 Global Natamycin Revenue and Growth Rate (2015-2026)
1.4.3 Global Natamycin Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Natamycin Industry Impact
1.5.1 How the Covid-19 is Affecting the Natamycin Industry
1.5.1.1 Natamycin Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Natamycin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Natamycin Players to Combat Covid-19 Impact
2 Natamycin Estimate and Forecast by Region
2.1 Global Natamycin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Natamycin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Natamycin Sales Market Share by Region (2015-2020)
2.2.2 Global Natamycin Revenue Market Share by Region (2015-2020)
2.3 Global Natamycin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Natamycin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Natamycin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Natamycin Estimates and Projections (2015-2026)
2.4.2 Europe Natamycin Estimates and Projections (2015-2026)
2.4.3 China Natamycin Estimates and Projections (2015-2026)
2.4.4 Japan Natamycin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Natamycin Estimates and Projections (2015-2026)
2.4.6 India Natamycin Estimates and Projections (2015-2026)
3 Global Natamycin Competition Landscape by Players
3.1 Global Top Natamycin Players by Sales (2015-2020)
3.2 Global Top Natamycin Players by Revenue (2015-2020)
3.3 Global Natamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natamycin as of 2019)
3.4 Global Natamycin Average Price by Company (2015-2020)
3.5 Manufacturers Natamycin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Natamycin Players (Opinion Leaders)
4 Global Natamycin Market Size by Type
4.1 Global Natamycin Historic Market Review by Type (2015-2020)
4.1.1 Global Natamycin Sales Market Share by Type (2015-2020)
4.1.2 Global Natamycin Revenue Market Share by Type (2015-2020)
4.1.3 Global Natamycin Price by Type (2014-2020)
4.2 Global Natamycin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Natamycin Sales Forecast by Type (2021-2026)
4.2.2 Global Natamycin Revenue Forecast by Type (2021-2026)
4.2.3 Global Natamycin Price Forecast by Type (2021-2026)
5 Global Natamycin Market Size by Application
5.1 Global Natamycin Historic Market Review by Application (2015-2020)
5.1.1 Global Natamycin Sales Market Share by Application (2015-2020)
5.1.2 Global Natamycin Revenue Market Share by Application (2015-2020)
5.1.3 Global Natamycin Price by Application (2015-2020)
5.2 Global Natamycin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Natamycin Sales Forecast by Application (2021-2026)
5.2.2 Global Natamycin Revenue Forecast by Application (2021-2026)
5.2.3 Global Natamycin Price Forecast by Application (2021-2026)
3 North America Natamycin Market Facts & Figures
3.2 North America Natamycin Sales Market Share by Company (2015-2020)
3.3 North America Natamycin Sales Market Share by Type (2015-2020)
3.4 North America Natamycin Sales Market Share by Application (2015-2020)
4 Europe Natamycin Market Facts & Figures
4.2 Europe Natamycin Sales Market Share by Company (2015-2020)
4.3 Europe Natamycin Sales Market Share by Type (2015-2020)
4.4 Europe Natamycin Sales Market Share by Application (2015-2020)
5 China Natamycin Market Facts & Figures
5.2 China Natamycin Sales Market Share by Company (2015-2020)
5.3 China Natamycin Sales Market Share by Type (2015-2020)
5.4 China Natamycin Sales Market Share by Application (2015-2020)
6 Japan Natamycin Market Facts & Figures
6.2 Japan Natamycin Sales Market Share by Company (2015-2020)
6.3 Japan Natamycin Sales Market Share by Type (2015-2020)
6.4 Japan Natamycin Sales Market Share by Application (2015-2020)
7 Southeast Asia Natamycin Market Facts & Figures
7.2 Southeast Asia Natamycin Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Natamycin Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Natamycin Sales Market Share by Application (2015-2020)
8 India Natamycin Market Facts & Figures
8.2 India Natamycin Sales Market Share by Company (2015-2020)
8.3 India Natamycin Sales Market Share by Type (2015-2020)
8.4 India Natamycin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Natamycin Business
12.1 Danisco
12.1.1 Danisco Natamycin Corporation Information
12.1.2 Danisco Natamycin Business Overview and Total Revenue
12.1.3 Danisco Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Danisco Natamycin Products Offered
12.1.5 Danisco Recent Development
12.2 DSM
12.2.1 DSM Natamycin Corporation Information
12.2.2 DSM Natamycin Business Overview and Total Revenue
12.2.3 DSM Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 DSM Natamycin Products Offered
12.2.5 DSM Recent Development
12.3 VGP
12.3.1 VGP Natamycin Corporation Information
12.3.2 VGP Natamycin Business Overview and Total Revenue
12.3.3 VGP Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 VGP Natamycin Products Offered
12.3.5 VGP Recent Development
12.4 Handary
12.4.1 Handary Natamycin Corporation Information
12.4.2 Handary Natamycin Business Overview and Total Revenue
12.4.3 Handary Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Handary Natamycin Products Offered
12.4.5 Handary Recent Development
12.5 AMTECH BIOTECH
12.5.1 AMTECH BIOTECH Natamycin Corporation Information
12.5.2 AMTECH BIOTECH Natamycin Business Overview and Total Revenue
12.5.3 AMTECH BIOTECH Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AMTECH BIOTECH Natamycin Products Offered
12.5.5 AMTECH BIOTECH Recent Development
12.6 Silver-Elephant
12.6.1 Silver-Elephant Natamycin Corporation Information
12.6.2 Silver-Elephant Natamycin Business Overview and Total Revenue
12.6.3 Silver-Elephant Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Silver-Elephant Natamycin Products Offered
12.6.5 Silver-Elephant Recent Development
12.7 Lanzhou Weiri
12.7.1 Lanzhou Weiri Natamycin Corporation Information
12.7.2 Lanzhou Weiri Natamycin Business Overview and Total Revenue
12.7.3 Lanzhou Weiri Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Lanzhou Weiri Natamycin Products Offered
12.7.5 Lanzhou Weiri Recent Development
12.8 Langfang Meihua
12.8.1 Langfang Meihua Natamycin Corporation Information
12.8.2 Langfang Meihua Natamycin Business Overview and Total Revenue
12.8.3 Langfang Meihua Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Langfang Meihua Natamycin Products Offered
12.8.5 Langfang Meihua Recent Development
12.9 Zhengzhou New Frey
12.9.1 Zhengzhou New Frey Natamycin Corporation Information
12.9.2 Zhengzhou New Frey Natamycin Business Overview and Total Revenue
12.9.3 Zhengzhou New Frey Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Zhengzhou New Frey Natamycin Products Offered
12.9.5 Zhengzhou New Frey Recent Development
12.10 Chihon
12.10.1 Chihon Natamycin Corporation Information
12.10.2 Chihon Natamycin Business Overview and Total Revenue
12.10.3 Chihon Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Chihon Natamycin Products Offered
12.10.5 Chihon Recent Development
12.11 Jiaozuo Joincare
12.11.1 Jiaozuo Joincare Natamycin Corporation Information
12.11.2 Jiaozuo Joincare Natamycin Business Overview and Total Revenue
12.11.3 Jiaozuo Joincare Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Jiaozuo Joincare Natamycin Products Offered
12.11.5 Jiaozuo Joincare Recent Development
12.12 Beijing Oriental Rada
12.12.1 Beijing Oriental Rada Natamycin Corporation Information
12.12.2 Beijing Oriental Rada Natamycin Business Overview and Total Revenue
12.12.3 Beijing Oriental Rada Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Beijing Oriental Rada Natamycin Products Offered
12.12.5 Beijing Oriental Rada Recent Development
12.13 Pucheng Lifecome
12.13.1 Pucheng Lifecome Natamycin Corporation Information
12.13.2 Pucheng Lifecome Natamycin Business Overview and Total Revenue
12.13.3 Pucheng Lifecome Natamycin Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Pucheng Lifecome Natamycin Products Offered
12.13.5 Pucheng Lifecome Recent Development
13 Natamycin Manufacturing Cost Analysis
13.1 Natamycin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Natamycin
13.4 Natamycin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Natamycin Distributors List
14.3 Natamycin Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Natamycin Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Natamycin Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Natamycin Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Natamycin Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Natamycin Players to Combat Covid-19 Impact
Table 8. Global Market Natamycin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Natamycin Sales (K Units) by Region (2015-2020)
Table 10. Global Natamycin Sales Market Share by Region (2015-2020)
Table 11. Global Natamycin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Natamycin Revenue Share by Region (2015-2020)
Table 13. Global Natamycin Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Natamycin Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Natamycin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Natamycin Revenue Share Forecast by Region (2021-2026)
Table 17. Global Natamycin (K Units) of Key Companies (2015-2020)
Table 18. Global Natamycin Sales Share by Company (2015-2020)
Table 19. Global Natamycin Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Natamycin Revenue Share by Company (2015-2020)
Table 21. Global Natamycin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natamycin as of 2019)
Table 22. Global Natamycin Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Natamycin Manufacturing Sites and Area Served
Table 24. Manufacturers Natamycin Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Natamycin Players
Table 27. Global Natamycin Sales (K Units) by Type (2015-2020)
Table 28. Global Natamycin Sales Share by Type (2015-2020)
Table 29. Global Natamycin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Natamycin Price (K Units) by Type (2015-2020)
Table 31. Global Natamycin Sales Share by Type (2021-2026)
Table 32. Global Natamycin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Natamycin Revenue Share by Type (2021-2026)
Table 34. Global Natamycin Price (K Units) by Type (2021-2026)
Table 35. Global Natamycin Sales (K Units) by Application (2015-2020)
Table 36. Global Natamycin Sales Share by Application (2015-2020)
Table 37. Global Natamycin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Natamycin Price (K Units) by Application (2015-2020)
Table 39. Global Natamycin Sales (K Units) by Application (2021-2026)
Table 40. Global Natamycin Sales Share by Application (2021-2026)
Table 41. Global Natamycin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Natamycin Revenue Share by Application (2021-2026)
Table 43. Global Natamycin Price (K Units) by Application (2021-2026)
Table 44. United States Natamycin Sales (K Units) by Company (2015-2020)
Table 45. United States Natamycin Sales Market Share by Company (2015-2020)
Table 46. United States Natamycin Sales (K Units) by Type (2015-2020)
Table 47. United States Natamycin Sales Market Share by Type (2015-2020)
Table 48. United States Natamycin Sales (K Units) by Application (2015-2020)
Table 49. United States Natamycin Sales Market Share by Application (2015-2020)
Table 50. Europe Natamycin Sales (K Units) by Company (2015-2020)
Table 51. Europe Natamycin Sales Market Share by Company (2015-2020)
Table 52. Europe Natamycin Sales (K Units) by Type (2015-2020)
Table 53. Europe Natamycin Sales Market Share by Type (2015-2020)
Table 54. Europe Natamycin Sales (K Units) by Application (2015-2020)
Table 55. Europe Natamycin Sales Market Share by Type (2015-2020)
Table 56. China Natamycin Sales (K Units) by Company (2015-2020)
Table 57. China Natamycin Sales Market Share by Company (2015-2020)
Table 58. China Natamycin Sales (K Units) by Type (2015-2020)
Table 59. China Natamycin Sales Market Share by Type (2015-2020)
Table 60. China Natamycin Sales (K Units) by Application (2015-2020)
Table 61. China Natamycin Sales Market Share by Application (2015-2020)
Table 62. Japan Natamycin Sales (K Units) by Company (2015-2020)
Table 63. Japan Natamycin Sales Market Share by Company (2015-2020)
Table 64. Japan Natamycin Sales (K Units) by Type (2015-2020)
Table 65. Japan Natamycin Sales Market Share by Type (2015-2020)
Table 66. Japan Natamycin Sales (K Units) by Application (2015-2020)
Table 67. Japan Natamycin Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Natamycin Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Natamycin Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Natamycin Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Natamycin Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Natamycin Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Natamycin Sales Market Share by Application (2015-2020)
Table 74. India Natamycin Sales (K Units) by Company (2015-2020)
Table 75. India Natamycin Sales Market Share by Company (2015-2020)
Table 76. India Natamycin Sales (K Units) by Type (2015-2020)
Table 77. India Natamycin Sales Market Share by Type (2015-2020)
Table 78. India Natamycin Sales (K Units) by Application (2015-2020)
Table 79. India Natamycin Sales Market Share by Application (2015-2020)
Table 80. Danisco Corporation Information
Table 81. Danisco Description and Business Overview
Table 82. Danisco Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Danisco Natamycin Product
Table 84. Danisco Recent Development
Table 85. DSM Corporation Information
Table 86. DSM Description and Business Overview
Table 87. DSM Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. DSM Natamycin Product
Table 89. DSM Recent Development
Table 90. VGP Corporation Information
Table 91. VGP Description and Business Overview
Table 92. VGP Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. VGP Natamycin Product
Table 94. VGP Recent Development
Table 95. Handary Corporation Information
Table 96. Handary Description and Business Overview
Table 97. Handary Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Handary Natamycin Product
Table 99. Handary Recent Development
Table 100. AMTECH BIOTECH Corporation Information
Table 101. AMTECH BIOTECH Description and Business Overview
Table 102. AMTECH BIOTECH Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. AMTECH BIOTECH Natamycin Product
Table 104. AMTECH BIOTECH Recent Development
Table 105. Silver-Elephant Corporation Information
Table 106. Silver-Elephant Description and Business Overview
Table 107. Silver-Elephant Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Silver-Elephant Natamycin Product
Table 109. Silver-Elephant Recent Development
Table 110. Lanzhou Weiri Corporation Information
Table 111. Lanzhou Weiri Description and Business Overview
Table 112. Lanzhou Weiri Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Lanzhou Weiri Natamycin Product
Table 114. Lanzhou Weiri Recent Development
Table 115. Langfang Meihua Corporation Information
Table 116. Langfang Meihua Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Langfang Meihua Description and Business Overview
Table 118. Langfang Meihua Natamycin Product
Table 119. Langfang Meihua Recent Development
Table 120. Zhengzhou New Frey Corporation Information
Table 121. Zhengzhou New Frey Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Zhengzhou New Frey Description and Business Overview
Table 123. Zhengzhou New Frey Natamycin Product
Table 124. Zhengzhou New Frey Recent Development
Table 125. Chihon Corporation Information
Table 126. Chihon Description and Business Overview
Table 127. Chihon Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Chihon Natamycin Product
Table 129. Chihon Recent Development
Table 130. Jiaozuo Joincare Corporation Information
Table 131. Jiaozuo Joincare Description and Business Overview
Table 132. Jiaozuo Joincare Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Jiaozuo Joincare Natamycin Product
Table 134. Jiaozuo Joincare Recent Development
Table 135. Beijing Oriental Rada Corporation Information
Table 136. Beijing Oriental Rada Description and Business Overview
Table 137. Beijing Oriental Rada Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Beijing Oriental Rada Natamycin Product
Table 139. Beijing Oriental Rada Recent Development
Table . Pucheng Lifecome Corporation Information
Table . Pucheng Lifecome Description and Business Overview
Table . Pucheng Lifecome Natamycin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Pucheng Lifecome Natamycin Product
Table . Pucheng Lifecome Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Natamycin Distributors List
Table 148. Natamycin Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Natamycin Product Picture
Figure 2. Global Natamycin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Natamycin Market Share by Application in 2020 & 2026
Figure 6. Food industry Examples
Figure 7. Medical Examples
Figure 8. Others Examples
Figure 9. Global Natamycin Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Natamycin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Natamycin Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Natamycin Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Natamycin Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Natamycin Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Natamycin Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Natamycin Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Natamycin Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Natamycin Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Natamycin Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Natamycin Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Natamycin Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Natamycin Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Natamycin Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Natamycin Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Natamycin Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Natamycin Players Market Share by Revenue in Natamycin 2015 & 2019
Figure 27. Natamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Natamycin Revenue Share by Type (2015-2020)
Figure 29. Global Natamycin Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Natamycin Revenue Share by Application (2015-2020)
Figure 31. Global Natamycin Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Natamycin Sales Market Share by Type in 2019
Figure 33. United States Natamycin Sales Market Share by Type in 2019
Figure 34. Europe Natamycin Sales Market Share by Company in 2019
Figure 35. Europe Natamycin Sales Market Share by Type in 2019
Figure 36. Europe Natamycin Sales Market Share by Application in 2019
Figure 37. China Natamycin Sales Market Share by Company in 2019
Figure 38. China Natamycin Sales Market Share by Type in 2019
Figure 39. China Natamycin Sales Market Share by Application in 2019
Figure 40. Japan Natamycin Sales Market Share by Company in 2019
Figure 41. Japan Natamycin Sales Market Share by Type in 2019
Figure 42. Japan Natamycin Sales Market Share by Application in 2019
Figure 43. Southeast Asia Natamycin Sales Market Share by Company in 2019
Figure 44. Southeast Asia Natamycin Sales Market Share by Type in 2019
Figure 45. Southeast Asia Natamycin Sales Market Share by Application in 2019
Figure 46. India Natamycin Sales Market Share by Company in 2019
Figure 47. India Natamycin Sales Market Share by Type in 2019
Figure 48. India Natamycin Sales Market Share by Application in 2019
Figure 49. Danisco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. DSM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. VGP Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Handary Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. AMTECH BIOTECH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Silver-Elephant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Lanzhou Weiri Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Langfang Meihua Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Zhengzhou New Frey Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Chihon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Jiaozuo Joincare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Beijing Oriental Rada Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Pucheng Lifecome Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Natamycin
Figure 64. Manufacturing Process Analysis of Natamycin
Figure 65. Natamycin Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
カビ防止剤の世界市場レポート2020 The global mold inhibitors market has high growth prospects, and has the potential to offer innumerable opportunities to new entrants in this market. Rising health-consciousness and more focused research & development in the pharmaceutical industry has increased the market share of this application …- カビ防止剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Mold Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mold Inhibitor market report p…
- 特別医療目的用食品(FSMP)の世界市場レポート2020 Foods for special medical purposes (FSMP) are a sub-category of foods intended for particular nutritional uses (PARNUT), also called “dietetic foods.” FSMPs are intended for the dietary management of diseases in patients with impaired digestive function such as absorption, making them the most medic…
- 食品産業用ロボットの世界市場レポート2020 Market Analysis and Insights: Global Food Industry Robot Market The global Food Industry Robot market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Food Industry Robot Scope and Market Size The global Food Ind…
- 医療用線形加速器の世界市場レポート2020 A recently published report by QY Research titled Global Medical Linear Accelerator Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides …